Demjanjuk’s Family Appeal Decision on Death
The family of John Demjanjuk appealed the decision by German prosecutors to close an investigation into the convicted Nazi war criminal’s death.
Prosecutors in the German state of Bavaria late last month determined that Demjanjuk’s death was not hastened by medication administered at a nursing home in Bavaria. Demjanjuk died while he was awaiting an appeal of his conviction last year by a Munich court for his role in the murder of 27,900 people at the Sobibor camp in Poland.
Ulrich Busch, an attorney for Demjanjuk, filed an appeal on Tuesday that said the decision contradicts “all medical knowledge” about the drug Novalgin, which was used to treat Demjanjuk, according to The Associated Press. The drug is common in Germany but banned in the United States and other countries.
Busch had filed a complaint in May with German prosecutors asking them to open an investigation of five doctors and a nurse, alleging that the pain medication they gave to Demjanjuk added to his kidney problems. Demjanjuk died in March at 91.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
